Trials / Withdrawn
WithdrawnNCT00556387
Efficacy of Ketamine in Children With Severe Brain Injury for Brain Cell Protection
Possible Neuroprotective Effects of Ketamine in Children With Severe Traumatic Brain Injury
- Status
- Withdrawn
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- University of Arkansas · Academic / Other
- Sex
- All
- Age
- 1 Month – 16 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine the possible effects of an anesthetic agent called Ketamine on the injured brain in children. The researchers think that it will effect the outcomes of children with these injuries.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | saline | 1 mg/kg IV bolus slowly over 1-2 minutes followed by 0.5 mg/kg IV continuous infusion over 48 hours or until discontinuation of ICP monitor (whichever occurs first) |
| DRUG | Ketamine | 1 mg/kg IV bolus slowly over 1-2 minutes, followed by 0.5 mg/kg IV continuous infusion for 48 hours or until discontinuation of ICP monitor (whichever occurs first) |
Timeline
- Start date
- 2008-12-01
- Primary completion
- 2012-12-01
- Completion
- 2012-12-01
- First posted
- 2007-11-12
- Last updated
- 2013-11-01
Source: ClinicalTrials.gov record NCT00556387. Inclusion in this directory is not an endorsement.